{"id":"W4387809673","doi":"10.1016/j.annonc.2023.10.029","title":"LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Hospital","funders":"Ipsen; Astellas Pharma; Eisai; AstraZeneca; University College London; Boston Scientific Corporation; Seagen; Pfizer","keywords":"Medicine; Open label; Chemotherapy; Oncology; Internal medicine; Phases of clinical research; Open label study; Surgery; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004004753,0.0003844377,0.003455864,0.0006031967,0.00004595542,0.00001625975,0.0008026914,0.0002224288,0.003593521],"category_scores_gemma":[0.002931101,0.0002806324,0.000151862,0.003645924,0.0006871311,0.0001297952,0.0004079011,0.000542736,0.00001518456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002426972,"about_ca_system_score_gemma":0.003412143,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006909725,"about_ca_topic_score_gemma":0.005570552,"domain_scores_codex":[0.9943428,0.001368814,0.002052577,0.0006501587,0.0008529972,0.0007326589],"domain_scores_gemma":[0.9952242,0.001943602,0.0008486073,0.0007511754,0.0008765862,0.0003558593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6870807,0.02487976,0.003867116,0.0009651425,0.002557575,0.0004240263,0.00410385,0.00001632316,0.02169738,0.0002179217,0.0306825,0.2235077],"study_design_scores_gemma":[0.8898019,0.0514466,0.00306569,0.00066186,0.0003757618,0.00004036561,0.001930864,0.0008130465,0.01413514,0.0004722461,0.03686219,0.0003943223],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832253,0.0008934624,0.000006074113,0.009231715,0.0002768083,0.005277921,0.0001174092,0.00003734327,0.000933897],"genre_scores_gemma":[0.9894304,0.004244332,0.0004858991,0.002815987,0.0001611612,0.001128736,0.0000581219,0.00008253026,0.001592801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2231134,"threshold_uncertainty_score":0.9999646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3080902739800833,"score_gpt":0.5448928587729979,"score_spread":0.2368025847929145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}